BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34725462)

  • 21. Anti-angiogenic pathway associations of the 3p21.3 mapped BLU gene in nasopharyngeal carcinoma.
    Cheng Y; Ho RL; Chan KC; Kan R; Tung E; Lung HL; Yau WL; Cheung AK; Ko JM; Zhang ZF; Luo DZ; Feng ZB; Chen S; Guan XY; Kwong D; Stanbridge EJ; Lung ML
    Oncogene; 2015 Aug; 34(32):4219-28. PubMed ID: 25347745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CDC42-interacting protein 4 promotes metastasis of nasopharyngeal carcinoma by mediating invadopodia formation and activating EGFR signaling.
    Meng DF; Xie P; Peng LX; Sun R; Luo DH; Chen QY; Lv X; Wang L; Chen MY; Mai HQ; Guo L; Guo X; Zheng LS; Cao L; Yang JP; Wang MY; Mei Y; Qiang YY; Zhang ZM; Yun JP; Huang BJ; Qian CN
    J Exp Clin Cancer Res; 2017 Jan; 36(1):21. PubMed ID: 28129778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-125b regulates proliferation and apoptosis of nasopharyngeal carcinoma by targeting A20/NF-κB signaling pathway.
    Zheng Z; Qu JQ; Yi HM; Ye X; Huang W; Xiao T; Li JY; Wang YY; Feng J; Zhu JF; Lu SS; Yi H; Xiao ZQ
    Cell Death Dis; 2017 Jun; 8(6):e2855. PubMed ID: 28569771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ginsenoside Rg3 inhibition of vasculogenic mimicry in pancreatic cancer through downregulation of VE‑cadherin/EphA2/MMP9/MMP2 expression.
    Guo JQ; Zheng QH; Chen H; Chen L; Xu JB; Chen MY; Lu D; Wang ZH; Tong HF; Lin S
    Int J Oncol; 2014 Sep; 45(3):1065-72. PubMed ID: 24938458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ΔNp63α is a super enhancer-enriched master factor controlling the basal-to-luminal differentiation transcriptional program and gene regulatory networks in nasopharyngeal carcinoma.
    Cai J; Chen S; Yi M; Tan Y; Peng Q; Ban Y; Yang J; Li X; Zeng Z; Xiong W; McCarthy JB; Li G; Li X; Xiang B
    Carcinogenesis; 2020 Sep; 41(9):1282-1293. PubMed ID: 31826234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular biology of BPIFB1 and its advances in disease.
    Li J; Xu P; Wang L; Feng M; Chen D; Yu X; Lu Y
    Ann Transl Med; 2020 May; 8(10):651. PubMed ID: 32566588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exosomal LBH inhibits epithelial-mesenchymal transition and angiogenesis in nasopharyngeal carcinoma via downregulating VEGFA signaling.
    Wu A; Luo N; Xu Y; Du N; Li L; Liu Q
    Int J Biol Sci; 2022; 18(1):242-260. PubMed ID: 34975330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expression.
    Su Y; Yu QH; Wang XY; Yu LP; Wang ZF; Cao YC; Li JD
    BMC Cancer; 2017 Jul; 17(1):477. PubMed ID: 28693517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. mTORC2-mediated PDHE1α nuclear translocation links EBV-LMP1 reprogrammed glucose metabolism to cancer metastasis in nasopharyngeal carcinoma.
    Zhang J; Jia L; Liu T; Yip YL; Tang WC; Lin W; Deng W; Lo KW; You C; Lung ML; Lung HL; Cheung AL; Tsao SW; Tsang CM
    Oncogene; 2019 Jun; 38(24):4669-4684. PubMed ID: 30745576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C2orf40 inhibits metastasis and regulates chemo-resistance and radio-resistance of nasopharyngeal carcinoma cells by influencing cell cycle and activating the PI3K/AKT/mTOR signaling pathway.
    Xie Z; Li W; Ai J; Xie J; Zhang X
    J Transl Med; 2022 Jun; 20(1):264. PubMed ID: 35676661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
    Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
    Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
    [No Abstract]   [Full Text] [Related]  

  • 32. C5a promotes the proliferation of human nasopharyngeal carcinoma cells through PCAF-mediated STAT3 acetylation.
    Cai K; Wan Y; Wang Z; Wang Y; Zhao X; Bao X
    Oncol Rep; 2014 Nov; 32(5):2260-6. PubMed ID: 25174320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urokinase-type plasminogen activator receptor signaling is critical in nasopharyngeal carcinoma cell growth and metastasis.
    Bao YN; Cao X; Luo DH; Sun R; Peng LX; Wang L; Yan YP; Zheng LS; Xie P; Cao Y; Liang YY; Zheng FJ; Huang BJ; Xiang YQ; Lv X; Chen QY; Chen MY; Huang PY; Guo L; Mai HQ; Guo X; Zeng YX; Qian CN
    Cell Cycle; 2014; 13(12):1958-69. PubMed ID: 24763226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel Smac mimetic APG-1387 demonstrates potent antitumor activity in nasopharyngeal carcinoma cells by inducing apoptosis.
    Li N; Feng L; Han HQ; Yuan J; Qi XK; Lian YF; Kuang BH; Zhang YC; Deng CC; Zhang HJ; Yao YY; Xu M; He GP; Zhao BC; Gao L; Feng QS; Chen LZ; Yang L; Yang D; Zeng YX
    Cancer Lett; 2016 Oct; 381(1):14-22. PubMed ID: 27424523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deficiency of pigment epithelium-derived factor in nasopharyngeal carcinoma cells triggers the epithelial-mesenchymal transition and metastasis.
    Zhang T; Yin P; Zhang Z; Xu B; Che D; Dai Z; Dong C; Jiang P; Hong H; Yang Z; Zhou T; Shao J; Xu Z; Yang X; Gao G
    Cell Death Dis; 2017 Jun; 8(6):e2838. PubMed ID: 28569772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN.
    Zhang LY; Ho-Fun Lee V; Wong AM; Kwong DL; Zhu YH; Dong SS; Kong KL; Chen J; Tsao SW; Guan XY; Fu L
    Carcinogenesis; 2013 Feb; 34(2):454-63. PubMed ID: 23125220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA HOTAIR regulates the expression of E-cadherin to affect nasopharyngeal carcinoma progression by recruiting histone methylase EZH2 to mediate H3K27 trimethylation.
    Yang FL; Wei YX; Liao BY; Wei GJ; Qin HM; Pang XX; Wang JL
    Genomics; 2021 Jul; 113(4):2276-2289. PubMed ID: 33965547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting FoxM1 inhibits proliferation, invasion and migration of nasopharyngeal carcinoma through the epithelial‑to-mesenchymal transition pathway.
    Yu C; Chen L; Yie L; Wei L; Wen T; Liu Y; Chen H
    Oncol Rep; 2015 May; 33(5):2402-10. PubMed ID: 25738652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-treatment with angiotensin-(1-7) inhibits tumor growth via autophagy by downregulating PI3K/Akt/mTOR signaling in human nasopharyngeal carcinoma xenografts.
    Lin YT; Wang HC; Chuang HC; Hsu YC; Yang MY; Chien CY
    J Mol Med (Berl); 2018 Dec; 96(12):1407-1418. PubMed ID: 30374682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
    Wang B; Gu Q; Li J
    Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.